Masimo Q3 2025 slides: Revenue up 8% despite tariff headwinds, guidance raised

Hinge Health's Q3 2025 earnings call revealed a disappointing earnings per share (EPS) report, leading to a decline in stock prices. Investors reacted negatively to the news, reflecting concerns about the company's financial performance.

Latham Group has reported its Q3 2025 results, showcasing impressive growth that outpaces the market, even though it missed earnings expectations. This performance highlights the company's resilience and potential for future success.

NeuroPace has reported impressive earnings for Q3 2025, surpassing expectations with a higher EPS than anticipated. The company also raised its guidance, indicating strong future performance and confidence in its growth strategy.

Veracyte's Q3 2025 earnings call revealed impressive results, surpassing EPS expectations. The company showcased strong financial performance, indicating growth and confidence in its future prospects.

CareDx reported its Q3 2025 revenue exceeded forecasts, showcasing strong performance in the market. However, despite the positive financial results, the company's stock experienced a dip, raising questions among investors about future growth.

Grocery Outlet has reported impressive earnings for Q3 2025, surpassing expectations with a higher EPS. This positive performance has led to a rise in their stock price, reflecting strong investor confidence.

Allegiant Travel Co. has reported disappointing earnings for the third quarter of 2025, missing market expectations. The earnings call revealed challenges the company faced, which may impact its future performance.

Finance of America reported impressive growth in Q3 2025 during their earnings call, highlighting strong performance and positive outlook for the future.

Seres Group Co., known for producing China's top luxury vehicle, is set to begin trading in Hong Kong after successfully raising HK$14.3 billion ($1.8 billion) in its public offering. This marks a significant milestone in the city's impressive year for new listings.

Lawmakers are expressing optimism about reaching a bipartisan agreement to end the government shutdown. President Trump has reiterated his call for Republicans to eliminate the Senate filibuster to facilitate the reopening of the government.

Hinge Health's Q3 2025 earnings call revealed a disappointing earnings per share (EPS) report, leading to a decline in stock prices. Investors reacted negatively to the news, reflecting concerns about the company's financial performance.

Latham Group has reported its Q3 2025 results, showcasing impressive growth that outpaces the market, even though it missed earnings expectations. This performance highlights the company's resilience and potential for future success.

Carvana's chief brand officer, Keeton, has sold $9.7 million worth of stock. This move has drawn attention as it reflects the company's current financial strategies and market position.

NeuroPace has reported impressive earnings for Q3 2025, surpassing expectations with a higher EPS than anticipated. The company also raised its guidance, indicating strong future performance and confidence in its growth strategy.